13th Bengaluru INDIA NANO 2024 brings together 1018 delegates, 3,000+ visitors
Bio Spectrum|September 2024
The 13th edition of Bengaluru INDIA NANO 2024, organised by the Department of Science & Technology, Government of Karnataka, Karnataka Science & Technology Promotion Society (KSTePS), and Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR) concluded on August 3 with participation of 1018 delegates, 11 countries including Korea, Morocco, USA, UK, France, Canada, Germany, Netherlands, Russia, Japan, and Poland, 49 exhibitors comprising 21 startups and 28 industry and institutes, and 200 posters. The exhibition had a footfall of 3,000+ visitors.
13th Bengaluru INDIA NANO 2024 brings together 1018 delegates, 3,000+ visitors

The conference featured 81 distinguished speakers across 41 sessions, exploring a broad range of topics from cutting-edge research to practical industry applications in nanotechnology. Over 200 young attendees participated in the pre-conference tutorials.

During the two days sessions on "Nano in Healthcare", Prof. Dhirendra Katti, Director, IIT Goa spoke on 'Development of a Vaccines/Nano vaccines for Multi-drug Resistant Diarrhoea'; Dr Jiban Jyoti Panda, Associate Professor, Institute of Nano Science and Technology, Mohali spoke on 'Brain targeting Small Molecular Nanomedicines', Prof. Biman B. Mandal, Professor, IIT Guwahati shared his views on 'Nano-Composite Silk Hydrogel for Spatiotemporal, Targeted and On-Demand Controlled Release of Chemotherapeutics: An In Vivo Approach toward Suppressing Solid Tumour Growth', This session was chaired by Prof. Swaminathan, Professor & Director, SASTRA University.

Dr Praveen Kumar Vemula, Faculty, DBT INSTEM chaired a second session on Nano in Healthcare in which Prof. Neetu Singh, Professor & Head, Center for Biomedical Engineering, Indian Institute of Technology Delhi shared her views on the topic '3D Liver Platforms For In-Situ Disease Staging' and in his presentation Prof. Bikramjit Basu, Professor, IISc Bangalore touched upon 'Size-tailored Gold Nanoparticles: Novel electroactuators to guide stem cell differentiation and as bacteriotoxic agents' and Prof. K. Uma Maheswari, Professor, Sastra University spoke on Smart Non-intervention for Therapy.

Dr Taslimarif Syed, CEO and Director, C- CAMP, moderated a panel discussion on 'Healthcare & Medical Electronics' with Dr Aditya Kulkarni,

この蚘事は Bio Spectrum の September 2024 版に掲茉されおいたす。

7 日間の Magzter GOLD 無料トラむアルを開始しお、䜕千もの厳遞されたプレミアム ストヌリヌ、9,000 以䞊の雑誌や新聞にアクセスしおください。

この蚘事は Bio Spectrum の September 2024 版に掲茉されおいたす。

7 日間の Magzter GOLD 無料トラむアルを開始しお、䜕千もの厳遞されたプレミアム ストヌリヌ、9,000 以䞊の雑誌や新聞にアクセスしおください。

BIO SPECTRUMのその他の蚘事すべお衚瀺
Sartorius Stedim Biotech opens new centre for bioprocess innovation in US
Bio Spectrum

Sartorius Stedim Biotech opens new centre for bioprocess innovation in US

Sartorius Stedim Biotech, a leading partner of the biopharmaceutical industry, has opened its new centre for Bioprocess Innovation in Marlborough, Massachusetts in the US.

time-read
1 min  |
BioSpectrum India Jan 2025
Agilent introduces innovative Mito-rOCR assay kit for mitochondrial research
Bio Spectrum

Agilent introduces innovative Mito-rOCR assay kit for mitochondrial research

Agilent Technologies Inc. has announced the new MitorOCR Assay Kit.

time-read
1 min  |
BioSpectrum India Jan 2025
Qiagen launches AI-extension of Ingenuity Pathway Analysis for automatic interpretation of biological data
Bio Spectrum

Qiagen launches AI-extension of Ingenuity Pathway Analysis for automatic interpretation of biological data

Qiagen has announced the launch of Ingenuity Pathway Analysis (IPA) Interpret, a new feature designed to simplify and accelerate the interpretation of complex biological data.

time-read
1 min  |
BioSpectrum India Jan 2025
Parse Biosciences announces expansion of Evercode BCR product line
Bio Spectrum

Parse Biosciences announces expansion of Evercode BCR product line

Parse Biosciences, a leader in scalable single cell sequencing solutions, has announced the expansion of its Evercode BCR product line to enable applications in mice.

time-read
1 min  |
BioSpectrum India Jan 2025
New technology for unambiguous detection of HIV genome using tailored fluorogenic tests
Bio Spectrum

New technology for unambiguous detection of HIV genome using tailored fluorogenic tests

A team of scientists at Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR), has developed a novel diagnostic technology known as the GQ Topology-Targeted Reliable Conformational Polymorphism (GQ-RCP) platform.

time-read
1 min  |
BioSpectrum India Jan 2025
Gene mutation likely cause for developing autism in early childhood: RGCB study
Bio Spectrum

Gene mutation likely cause for developing autism in early childhood: RGCB study

Autism, a developmental disorder that causes functional abnormalities in brain development, is caused by a combination of environmental and genetic factors with its symptoms manifesting in childhood as early as the age of two years.

time-read
1 min  |
BioSpectrum India Jan 2025
IIIT-Delhi unveils AI platform for discovering molecules that promote healthy ageing
Bio Spectrum

IIIT-Delhi unveils AI platform for discovering molecules that promote healthy ageing

A team of researchers from Indraprastha Institute of Information Technology Delhi (IIIT-Delhi) has developed AgeXtend, a groundbreaking artificial intelligence (AI)-based platform that is set to transform the search for molecules promoting healthy ageing.

time-read
1 min  |
BioSpectrum India Jan 2025
RSSDI study lays focus on Yoga and Diabetes Prevention
Bio Spectrum

RSSDI study lays focus on Yoga and Diabetes Prevention

Dr Jitendra Singh, Union Minister of State (Independent Charge) for Science and Technology, recently released the landmark study by Research Society for Study of Diabetes in India (RSSDI) on 'Yoga and Diabetes Prevention'.

time-read
1 min  |
BioSpectrum India Jan 2025
Dr Alok Khullar steps in as Group CEO of RJ Corp Healthcare
Bio Spectrum

Dr Alok Khullar steps in as Group CEO of RJ Corp Healthcare

RJ Corp Healthcare, a leading name in the healthcare sector through its renowned entities Cocoon Hospital and Cryoviva Stem Cell Bank, has announced the appointment of Dr Alok Khullar as Group Chief Executive Officer (CEO).

time-read
1 min  |
BioSpectrum India Jan 2025
Entod Pharmaceuticals on-boards Dr Anish Desai as Scientific & Research adviser
Bio Spectrum

Entod Pharmaceuticals on-boards Dr Anish Desai as Scientific & Research adviser

Mumbai-based Entod Pharmaceuticals has appointed Dr Anish Desai as its Scientific and Research Adviser.

time-read
1 min  |
BioSpectrum India Jan 2025